OssDsign Q1: A slowdown in sales but case intact
Research Note
2021-04-19
16:32
Redeye comments on OssDsign’s Q1 report and continues to have a positive view on the case, despite a decrease in sales as US vaccine rollouts accelerate and its cash position is refuelled.
OB
Oscar Bergman
Disclosures and disclaimers